135 related articles for article (PubMed ID: 8674569)
1. Estrogen and progesterone receptor content of GnRH analogue pretreated and untreated uterine leiomyomata.
Regidor PA; Schmidt M; Callies R; Kato K; Schindler AE
Eur J Obstet Gynecol Reprod Biol; 1995 Nov; 63(1):69-73. PubMed ID: 8674569
[TBL] [Abstract][Full Text] [Related]
2. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
3. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
4. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
[TBL] [Abstract][Full Text] [Related]
5. Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas.
Uemura T; Mori J; Yoshimura Y; Minaguchi H
Asia Oceania J Obstet Gynaecol; 1991 Dec; 17(4):315-20. PubMed ID: 1724899
[TBL] [Abstract][Full Text] [Related]
6. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates of leiomyoma estrogen and progesterone receptors among Nigerian women.
Awowole IO; Makinde ON; Badejoko OO; Omoniyi-Esan GO; Tijani AM; Ajenifuja KO; Loto OM
Int J Gynaecol Obstet; 2016 Dec; 135(3):314-318. PubMed ID: 27599599
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens.
Ichimura T; Kawamura N; Ito F; Shibata S; Minakuchi K; Tsujimura A; Umesaki N; Ogita S
Fertil Steril; 1998 Nov; 70(5):967-71. PubMed ID: 9806586
[TBL] [Abstract][Full Text] [Related]
9. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Kuhlmann M; Gärtner A; Schindler EM; Regidor PA; Bühler K; Schindler AE
Gynecol Endocrinol; 1997 Jun; 11(3):169-74. PubMed ID: 9209897
[TBL] [Abstract][Full Text] [Related]
10. Metachromasia of the endocervical epithelium in women treated with gonadotropin releasing hormone agonist.
Morimura M; Ishiko O; Honda KI; Sumi T; Kawamura N; Wakasa K; Haba T; Ogita S
Int J Mol Med; 2001 Sep; 8(3):319-21. PubMed ID: 11494062
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
12. Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.
Deligdisch L; Hirschmann S; Altchek A
Fertil Steril; 1997 May; 67(5):837-41. PubMed ID: 9130887
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
14. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
[TBL] [Abstract][Full Text] [Related]
15. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma.
Abulafia O; Kleinhaus K; Levi G; Lee YC; Sherer DM
Gynecol Obstet Invest; 2001; 52(2):108-13. PubMed ID: 11586038
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium.
Chrapusta S; Konopka B; Paszko Z; Sieinski W; Szamborski J
Eur J Gynaecol Oncol; 1990; 11(4):275-81. PubMed ID: 2245811
[TBL] [Abstract][Full Text] [Related]
17. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy.
Dou Q; Zhao Y; Tarnuzzer RW; Rong H; Williams RS; Schultz GS; Chegini N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3222-30. PubMed ID: 8784073
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
Nisolle M; Gillerot S; Casanas-Roux F; Squifflet J; Berliere M; Donnez J
Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
[TBL] [Abstract][Full Text] [Related]
19. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
Vollenhoven BJ; Pearce P; Herington AC; Healy DL
Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]